AORT vs TNDM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AORT · Artivion$20.21 ▼ 20.21%
TNDM · Tandem Diabetes Care$16.91 ▼ 6.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AORT -55.1%
- TNDM +3.3%
Head to head
| Metric | AORT | TNDM |
|---|---|---|
| Price | $20.21 | $16.91 |
| Change today | ▼ 20.21% | ▼ 6.00% |
| Market cap | $986.05M | $1.18B |
| Return, 3 months | -23.2% | -25.9% |
| Return, year to date | -55.7% | -23.1% |
| Return, 1 year | -55.0% | +4.0% |
| P/E (TTM) | – | – |
| P/B | 2.2 | 8.7 |
| P/E percentile vs own 5y | 9th | 20th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +11.3% | +5.8% |
| Net profit growth (YoY) | -1,104.5% | +59.6% |
| Gross margin | 64.4% | 56.0% |
| Operating margin | 2.9% | -4.4% |
| Net margin | -0.7% | -6.1% |
| Return on equity | -0.7% | -48.0% |
| Analyst target vs. price | +99.5% | +65.6% |
| Analyst buy share | 100% | 58% |
| RSI (14) | 38 | 45 |
| 30-day volatility | 82.5% | 55.5% |
| Max drawdown, 1 year | -57.8% | -54.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TNDM is the largest of the group by market value.
- TNDM has returned the most over the past year.
- AORT is growing revenue fastest.
- AORT keeps the most profit per dollar of sales.
- TNDM has been the calmest stock over the last 30 days.